Tag Archives: SMPQY

Hot Stocks To Invest In Right Now

President Trump’s seemingly top priority is to keep the promises he made on the campaign trail and remake the federal government.

But judging from his first set of budget proposals to Congress, doing so is likely to come at the expense of those in need.

Advocates for lower-income Americans see the president’s proposed spending cuts in his “skinny” budget as an assault.

“This isn’t a budget that will make America great again. It’s a budget that will increase hardship and poverty,” said Robert Greenstein, president of the liberal Center on Budget and Policy Priorities.

When asked at a press briefing if the president’s spending blueprint is hard-hearted because it would cut programs that help low-income children and seniors, White House Budget Director Mick Mulvaney said he felt it was “as compassionate as you can get.”

“You’re only focusing on half of the equation, right? You’re focusing on recipients of the money. We’re trying to focus on both the recipients of the money and the folks who give us the money in the first place. [I]t’s fairly compassionate to go to them and say, look, ‘We’re not going to ask you for your hard-earned money anymore … unless we can guarantee to you that that money is actually being used in a proper function.”

Hot Stocks To Invest In Right Now: Lumber Liquidators Holdings, Inc(LL)

Advisors’ Opinion:

  • [By Daniel Miller]

    If you remember about a year ago, the Centers for Disease Control and Prevention let the world know that consumers who had purchased the China-produced flooring from Lumber Liquidators Holdings (NYSE:LL) were roughly three times more likely to fall ill with cancer. That rate was much higher than earlier calculations following the 2015 broadcast by CBS’ 60 Minutes.The stock shed much of its value since the 2015 airing, but rebounded 17% on Tuesday after it reported a narrower-than-expected loss during the fourth quarter, offering investors a slight amount of hope going forward.

  • [By Peter Graham]

    Small cap hardwood flooring stockLumber Liquidators Holdings Inc (NYSE: LL) reportedQ2 2017 earnings before the market opened this morning with better than expected earnings sending shares soaring as the Company went into earnings with short interest of 24.68% according to Highshortinterest.com. Net sales increased10.7% to $263.5 million as net sales in comparable stores increased 8.8% driven by a 5.3% increase in the number of customers invoiced and a 3.5% increase in the average sale. Merchandise sales in comparable stores grew 6.1% in the quarter whilenet sales in non-comparable stores increased $4.4 million. The Company did not open any stores during the second quarter of 2017 with the total store count remaining at 385 as of June 30, 2017. Net income was $4.5 million versusa net loss of $12.2 million for the first profit in the wake of a 2015 “60 Minutes” report that claimed the Companys laminate flooring contained high levels of cancer-causing formaldehyde.

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap hardwood flooring stockLumber Liquidators Holdings Inc (NYSE: LL) is scheduled for before the market opens onTuesday (February 21th). Lumber Liquidators Holdingshad been ahighflying stock until the middle of 2013 when shares were hit be allegations that the companys flooring products contained illegal levels of formaldehyde. Shares then took another hit on reports that the Department of Homeland Security andthe USFish and Wildlife Servicehad executed a sealed court-issuedsearch/raid on theheadquarters for possible sourcing violations.Lumber Liquidators Holdingslater won a favorable ruling in a California lawsuit filed under the state’s Proposition 65 covering cancer-causing chemicals and agreed to pay $2.5 million (without admitting wrongdoing) to settle a civil matter with the California Air Resources Board.

Hot Stocks To Invest In Right Now: PetroChina Company Limited(PTR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    PetroChina Co. Ltd. (NYSE ADR: PTR) is China’s largest oil company with a market cap of $216.52 billion. PTR is partially owned by the Chinese government.

Hot Stocks To Invest In Right Now: Lithium X Energy Corp. (LIXXF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

  • [By Tom Bishop]

    Lithium X Energy NPV (LIXXF) owns 50% of the Sal de los Angeles lithium brine project in the prolific “Lithium Triangle” in mining friendly Salta province, Argentina.

Hot Stocks To Invest In Right Now: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The majority owner is Sun Pharma (OTC:SMPQY) (the largest drug business in India). There have been a number of articles that have outlined Sun Pharma and its quest for Taro, but it makes a lot of sense for Sun to want to own all – and not just the majority – of Taro. One big reason is that owning all of Taro means that any investments that Sun makes with Taros $1.2 billion cash hoard will not be diluted by the presence of minority shareholders. Another reason that Sun likely wants Taro is simply because it is very cheap right now. Sun is run by its founder and majority shareholder, Dilip Shanghvi, who is sort of a pharmaceutical value investor who has opportunistically made acquisitions and investments over time, building his firm starting with a loan of $200 in the early 1980s to the multi-billion business it is today.

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ

best stocks to purchase today

Lockheed Martin stock (NYSE: LMT) is surging over 6% today (Tuesday) intraday. And this confirms the bullish outlook we’ve maintained on the Lockheed Martin stock price.

Lockheed Martin stock’s share bump is from its stellar third-quarter earnings report, which it posted today.

Lockheed’s net sales for the quarter grew to $2.4 billion, up from $865 million from Q3 2015. The defense giant also posted adjusted earnings per share of $3.61, which smashed analysts’ consensus estimate of $2.89 per share, according to FactSet.

Another reason LMT is rising today: The company boosted its quarterly dividend 10% to $1.82 per share. It also increased share repurchases to $2 billion.

Looking forward, Lockheed raised its guidance for the end of 2016. It now expects earnings of $12.10 per share with revenue of $46.5 billion. Those numbers are $0.95 per share and $1.5 billion higher than its previous guidance estimate, respectively.

best stocks to purchase today: Vanguard Short-Term Government ETF(VGSH)

Advisors’ Opinion:

  • [By Donald van Deventer]

    Shorter-duration Treasury Exchange-Traded Funds: (SHY), (SHV), (IEI), (BIL), (TUZ), (FIVZ), (DTUL), (VGSH), (DTUS), (DFVS), (DFVL), (SST), (ISTB), (TBZ).

best stocks to purchase today: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The majority owner is Sun Pharma (OTC:SMPQY) (the largest drug business in India). There have been a number of articles that have outlined Sun Pharma and its quest for Taro, but it makes a lot of sense for Sun to want to own all – and not just the majority – of Taro. One big reason is that owning all of Taro means that any investments that Sun makes with Taros $1.2 billion cash hoard will not be diluted by the presence of minority shareholders. Another reason that Sun likely wants Taro is simply because it is very cheap right now. Sun is run by its founder and majority shareholder, Dilip Shanghvi, who is sort of a pharmaceutical value investor who has opportunistically made acquisitions and investments over time, building his firm starting with a loan of $200 in the early 1980s to the multi-billion business it is today.

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ

Top 10 Clean Energy Stocks To Own For 2018

Flickr

Shares of Foster City, California-based, biotech major, Gilead Sciences, Inc(NASDAQ:GILD) have been on a consistent decline in the last one year or so. After being one of the best performers in the biotech space since 2012, Gilead stock has lost more than 12% in last one year, while theNasdaq Composite (INDX:COMPX) has gained by more than 24% in the same period, resulting in a massive underperformance. Gilead stock has underperformedeven the iShares NASDAQ Biotech Index ETF (NASDAQ:IBB) which has returned more than 14% during the same period. Gilead stock has been making lower lows and lower highs going into the earnings, indicating a clear downtrend in the stock. The stock hit its 52 week low of $69.78 recently on January 24th, just days ahead of its Q4 earnings result. Gilead Sciences, Incis scheduled to report its Q4 2016 and FY 2016 earnings on 7th of February, after the market close.

Top 10 Clean Energy Stocks To Own For 2018: Prestige Brand Holdings Inc.(PBH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Castor believes the cash has disappeared into working capital, which has grown from 23% to more than 50% since 2008. Comparable company PrestigeBrand (PBH) uses 11%; Unilever(UL) and Colgate-Palmolive(CL) far less.

Top 10 Clean Energy Stocks To Own For 2018: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ

Hot Blue Chip Stocks To Watch For 2018

On Tuesday, stocks closed mixed with a preference for small-caps as they took gains in some blue chips and big-cap stocks.

Profit-taking started immediately, with a divergence of better-quality stocks being sold. Banks and other financials fell 1.4% at the close, while technology gained 0.9% and consumer discretionary rose 0.5%. Eight of the eleven sectors of the 500 lost ground. From the election until Monday most investing was based on the expectations that the new administration will increase fiscal spending and lower corporate tax rates. The goal is to raise interest rates, inflation and promote growth.

Yesterday buying slowed slightly, but floor traders said that consolidations are a good sign and that the “reflation trade” will probably resume again. The chief investment officer at Wells Fargo Private Bank was quoted by The Wall Street Journal who said “there’s a level of optimism I haven’t seen in a while.”

Crude oil WTI fell 0.7% at $45.56 per barrel due to an EIA report that crude oil supplies increased by 5.27 million barrels instead of an estimate of 1.48 million.

Hot Blue Chip Stocks To Watch For 2018: OneBeacon Insurance Group, Ltd.(OB)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Hot Blue Chip Stocks To Watch For 2018: Preferred Bank(PFBC)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Preferred Bank (PFBC) has surged 54% in the past year but still trades at a modest discount to the median S&P 1500 regional bank, based on both trailing earnings and estimated 2017 profits.

Hot Blue Chip Stocks To Watch For 2018: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

Hot Blue Chip Stocks To Watch For 2018: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The majority owner is Sun Pharma (OTC:SMPQY) (the largest drug business in India). There have been a number of articles that have outlined Sun Pharma and its quest for Taro, but it makes a lot of sense for Sun to want to own all – and not just the majority – of Taro. One big reason is that owning all of Taro means that any investments that Sun makes with Taros $1.2 billion cash hoard will not be diluted by the presence of minority shareholders. Another reason that Sun likely wants Taro is simply because it is very cheap right now. Sun is run by its founder and majority shareholder, Dilip Shanghvi, who is sort of a pharmaceutical value investor who has opportunistically made acquisitions and investments over time, building his firm starting with a loan of $200 in the early 1980s to the multi-billion business it is today.

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ

stock market simulator

On Friday, our Under the Radar Moversnewsletter suggested enriched uranium stock Centrus Energy Corp (NYSEMKT: LEU) as a bullish trade:

This is a name that’s been on our watchlist for a while. It’s not red hot, but that’s why we like it. We’ve got a feeling that the past few weeks of consolidation has built up a head of steam, and the bulls just need the right nudge. Bolstering the bullish argument is the way LEU is increasingly finding support at its key moving average lines.

Our Under the Radar Moversnewsletter has a more detailed discussion about Centrus Energy Corps technical chart along with a bullish trading strategy:

stock market simulator: Fifth Street Asset Management Inc.(FSAM)

Advisors’ Opinion:

  • [By Jordan Wathen]

    Last week,The Wall Street Journal broke the news that Fifth Street Asset Management (NASDAQ:FSAM) was on the auction block, apparently for the second time.

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

stock market simulator: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The majority owner is Sun Pharma (OTC:SMPQY) (the largest drug business in India). There have been a number of articles that have outlined Sun Pharma and its quest for Taro, but it makes a lot of sense for Sun to want to own all – and not just the majority – of Taro. One big reason is that owning all of Taro means that any investments that Sun makes with Taros $1.2 billion cash hoard will not be diluted by the presence of minority shareholders. Another reason that Sun likely wants Taro is simply because it is very cheap right now. Sun is run by its founder and majority shareholder, Dilip Shanghvi, who is sort of a pharmaceutical value investor who has opportunistically made acquisitions and investments over time, building his firm starting with a loan of $200 in the early 1980s to the multi-billion business it is today.

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ

stock market numbers today

President Donald Trump promised both corporate tax reform and individual tax cuts during his campaign as part of his “America First” strategy. But investors may have to wait until next year to see the promise come to fruition.
According to President Trump, the tax cuts are still being worked on – including his promised 15% corporate tax rate. “We’ll see what happens, but I hope it’s going to be 15%,” Trump said Sunday (Sept. 24) while preparing to board Air Force One, according to The Washington Post.

The proposed corporate tax rate is a whopping 20% lower than the current 35% standard, something business leaders are anxiously awaiting.

“15% would be terrific,” said Joshua Bolten, president and CEO of the Business Roundtable, a business lobby that represents many of America’s largest companies, to The Post.

However, amid all the brouhaha in Washington over the failed healthcare bill and threats of nuclear war from North Korea, these tax cuts may have to come later rather than sooner.

stock market numbers today: Del Taco Restaurants, Inc.(TACO)

Advisors’ Opinion:

  • [By Lee Jackson]

    Del Taco Restaurants Inc. (NASDAQ: TACO) had a director at the company selling stock last week. The board member shed a total of 831,314 sharesat between $11.40 and $11.84 apiece. The total for the sale was $10 million. The shares ended the weekat $12.36, in a 52-week range of$8.43 to $15.32. The consensus price target is $17.07.

  • [By WWW.THESTREET.COM]

    Cramer’s game plan starts on Monday, with earnings from Del Taco Restaurants (TACO)  . Despite strong same-store sales last quarter, Cramer said he’s expecting a struggle this quarter.

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggested shorting small cap Mexican restaurant stock Del Taco Restaurants (NASDAQ: TACO):

    The downtrend here is clearly well established, But, it cemented itself in place yesterday and today. On Monday the bulls took a shot, pushing and up and off of the 200-day moving average line (green) after finding support there last week. It was a short-lived effort, setting up a drastic change of heart – the people who regretted not getting out a month ago took the small uptick as a second chance to do so. Only this time, the sellers weren’t so shy. TACO broker under the 200-day moving average that had been support just a week earlier, and did so on higher volume. Today’s bearish follow-through is the clincher.

  • [By Peter Graham]

    Small cap Mexican restaurant stock Del Taco Restaurants (NASDAQ: TACO) reported fiscal Q3 2017 earnings after the market closed on Thursday with earnings meeting Wall Street expectations plus the Company also revised its guidance for fiscal year 2017 on several key metrics. Total revenuerose 6.3% to$111.0 million driven by a 6.1% increase in Company restaurant sales and a 7.9% increase in franchise revenue. Comparable restaurant sales increased 4.1% system-wide for the fiscal third quarter 2017, resulting in a 10.8% increase on a two-year basis. The Del Taco system has now generated comparable restaurant sales growth for 16 consecutive quarters whileCompany-operated comparable restaurant sales increased 3.7% marking the 21st consecutive quarter of comparable restaurant sales growth. Franchise comparable restaurant sales increased 4.6%. Net income was $5.1 million versus$4.9 million. The CEO commented:

stock market numbers today: XTL Biopharmaceuticals Ltd.(XTLB)

Advisors’ Opinion:

  • [By Lisa Levin]

    X T L Biopharmaceuticals Ltd (ADR) (NASDAQ: XTLB) shares dropped 38 percent to $2.21 after the company reported a $2.5 million registered direct offering.

stock market numbers today: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) reportedQ1 2017 earnings as net revenues increased 8.0% to $72.7 million (above the high end of the Company’s guidance of $72.0 million). Net revenues from product sales were $64.8 million versus$61.9 million and net revenues from service and others were $7.9 million versus $5.4 million in the same quarter of 2016. As a percentage of net revenues, service and others accounted for 10.9% during the first quarter of 2017. Total orders of product sales were 1.6 million for the first quarter of 2017 versus1.7 million in the same quarter of 2016 while the total number of product sales customers was 1.2 million versus 1.4 million.

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) as a long/buy trade:

stock market numbers today: Entercom Communications Corporation(ETM)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap radio broadcasting stock Entercom Communications Corp (NYSE: ETM), a potential peer of Emmis Communications Corporation (NASDAQ: EMMS), Saga Communications (NYSEAMERICAN: SGA) and troubled Cumulus Media (NASDAQ: CMLS), is the tenth most shorted stock on the NYSE with short interest of 45.06% according to Highshortnterest.com.

stock market numbers today: Barnes & Noble, Inc.(BKS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Chegg Inc finallymovingabove IPO levels while potential performance benchmarks such as Houghton Mifflin Harcourt Co (NASDAQ: HMHC) and Barnes & Noble Education Inc (NYSE: BNED), a spin off from Barnes & Noble, Inc (NYSE: BKS), have seen their performance slip:

  • [By Peter Graham]

    A long term performance chart shows Chegg Inc and potentialsmall cap performance benchmarksHoughton Mifflin Harcourt Co (NASDAQ: HMHC)and Barnes & Noble Education Inc (NYSE: BNED), a spin off from Barnes & Noble, Inc (NYSE: BKS), slipping into underperformance:

  • [By Paul Ausick]

    Bookseller Barnes & Noble Inc. (NYSE: BKS) posted its highest-ever stock price at above $45 a share in March of 2006. By March of 2011 it had dropped below $9 a share, and it posted a new all-time low of $7.25 in February of last year.

  • [By Ben Levisohn]

    The folks at Bespoke Investment Group note that its “Death By Amazon” index, which includesBest Buy (BBY), Barnes & Noble (BKS), Wal-Mart Stores (WMT), and Macy’s (M), among other traditional retailers that have been hurt by Amazon.com’s (AMZN) dominance, has been outperforming since Donald Trump’s election victory:

  • [By Kumar Abhishek]

    Apart from eCommerce growth, another reason why some analysts are bullish on Amazon is because of itsgrowing offline presence. In anirony of sorts, Amazon.com, Inc which made its name by disrupting the brick-and-mortar retail market is planning on more physical presence. According to a New York Times article, Amazon is going to make a strong push in the bookstore, groceryand furniture segments. Recently, Amazon opened its first store in the same mall where the giant Barnes & Noble (NYSE:BKS) had its bookstore before Amazon disrupted the publishing industry. For every store that Barnes and Noble will close this year, Amazon is likely to open a new one. Amazon is also opening more grocery shops and fulfillment centers, including one in India. But given the recent chaos in the brick-and-mortar retail space, why is Amazon.com Inc planning to enter this space?

stock market numbers today: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ